EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension

Robin Knuchel, Zoran Erlic, Sven Gruber, Laurence Amar, Casper K Larsen, Anne-Paule Gimenez-Roqueplo, Paolo Mulatero, Martina Tetti, Alessio Pecori, Christina Pamporaki, Katharina Langton, Mirko Peitzsch und 13 weitere

Frontiers in Endocrinology · 2024

DOI: 10.3389/fendo.2024.1370525 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Endocrinology, 2024. Verfasst von Robin Knuchel und 24 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich (USZ) und Universität Zürich (UZH), Zurich, Switzerland. Hauptthemen laut MEDLINE: Cortisone, Cushing Syndrome, Adrenal Gland Neoplasms, Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, Universität Zürich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endocrine hypertension (EHT) due to pheochromocytoma/paraganglioma (PPGL), Cushing’s syndrome (CS), or primary aldosteronism (PA) is linked to a variety of metabolic alterations and comorbidities. Accordingly, patients with EHT and primary hypertension (PHT) are characterized by distinct metabolic profiles. However, it remains unclear whether the metabolomic differences relate solely to the disease-defining hormonal parameters. Therefore, our objective was to study the association of disease defining hormonal excess and concomitant adrenal steroids with metabolomic alterations in patients with EHT.

Methods

Retrospective European multicenter study of 263 patients (mean age 49 years, 50% females; 58 PHT, 69 PPGL, 37 CS, 99 PA) in whom targeted metabolomic and adrenal steroid profiling was available. The association of 13 adrenal steroids with differences in 79 metabolites between PPGL, CS, PA and PHT was examined after correction for age, sex, BMI, and presence of diabetes mellitus.

Results

After adjustment for BMI and diabetes mellitus significant association between adrenal steroids and metabolites – 18 in PPGL, 15 in CS, and 23 in PA – were revealed. In PPGL, the majority of metabolite associations were linked to catecholamine excess, whereas in PA, only one metabolite was associated with aldosterone. In contrast, cortisone (16 metabolites), cortisol (6 metabolites), and DHEA (8 metabolites) had the highest number of associated metabolites in PA. In CS, 18-hydroxycortisol significantly influenced 5 metabolites, cortisol affected 4, and cortisone, 11-deoxycortisol, and DHEA each were linked to 3 metabolites. Discussions Our study indicates cortisol, cortisone, and catecholamine excess are significantly associated with metabolomic variances in EHT versus PHT patients. Notably, catecholamine excess is key to PPGL’s metabolomic changes, whereas in PA, other non-defining adrenal steroids mainly account for metabolomic differences. In CS, cortisol, alongside other non-defining adrenal hormones, contributes to these differences, suggesting that metabolic disorders and cardiovascular morbidity in these conditions could also be affected by various adrenal steroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CortisoneCushing SyndromeAdrenal Gland NeoplasmsHypertensionPheochromocytomaParagangliomaDiabetes MellitusFemaleHumansMiddle AgedMaleHydrocortisoneRetrospective StudiesSteroidsCatecholaminesDehydroepiandrosterone

Stichwörter der Autor:innen

Cushing’s syndromeadrenal steroidsendocrine hypertensionmetabolomicspheochromocytomaprimary aldosteronismprimary hypertension

Substanzen

HydrocortisoneCortisoneSteroidsCatecholaminesDehydroepiandrosterone

Autor:innen und Institutionen

  • Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich (USZ) und Universität Zürich (UZH), Zurich, Switzerland.
  • Université Paris Cité, Paris Cardiovascular Research Center (PARCC), L'Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
  • Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
  • Centre de référence en maladies rares de la surrénale, Hôpital Européen Georges Pompidou, Paris, France.
  • Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, Italy.
  • Medical Clinic III, University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Förderung

  • Horizon 2020 Framework Programme
  • Universität Zürich

Zitieren

APA

Knuchel, R., Erlic, Z., Gruber, S., Amar, L., Larsen, C. K., Gimenez-Roqueplo, A. P., Mulatero, P., Tetti, M., Pecori, A., Pamporaki, C., Langton, K., Peitzsch, M., Ceccato, F., Prejbisz, A., Januszewicz, A., Adolf, C., Remde, H., Lenzini, L., Dennedy, M., …, & Beuschlein, F. (2024). Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1370525

Vancouver

Knuchel R, Erlic Z, Gruber S, Amar L, Larsen CK, Gimenez-Roqueplo AP, et al. Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension. Frontiers in Endocrinology. 2024. doi:10.3389/fendo.2024.1370525

BibTeX
@article{Knuchel2024,
  author = {Knuchel, Robin and Erlic, Zoran and Gruber, Sven and Amar, Laurence and Larsen, Casper K and Gimenez-Roqueplo, Anne-Paule and Mulatero, Paolo and Tetti, Martina and Pecori, Alessio and Pamporaki, Christina and Langton, Katharina and Peitzsch, Mirko and Ceccato, Filippo and Prejbisz, Aleksander and Januszewicz, Andrzej and Adolf, Christian and Remde, Hanna and Lenzini, Livia and Dennedy, Michael and Deinum, Jaap and Jefferson, Emily and Blanchard, Anne and Zennaro, Maria-Christina and Eisenhofer, Graeme and Beuschlein, Felix},
  title = {Association of adrenal steroids with metabolomic profiles in patients with primary and endocrine hypertension},
  journal = {Frontiers in Endocrinology},
  year = {2024},
  doi = {10.3389/fendo.2024.1370525}
}
Kostenlos starten →